Home/Filings/4/0001562180-19-004090
4//SEC Filing

Kanes Stephen 4

Accession 0001562180-19-004090

CIK 0001597553other

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 7:59 PM ET

Size

6.4 KB

Accession

0001562180-19-004090

Insider Transaction Report

Form 4
Period: 2019-07-25
Kanes Stephen
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-07-25+1,9002,841 total
  • Tax Payment

    Common Stock

    2019-07-25$161.38/sh549$88,5982,292 total
Footnotes (1)
  • [F1]On February 13, 2019, the reporting person was granted Performance Stock Units (PSU) to acquire a total of 9,500 shares of common stock. The PSU vests upon the achievement of certain milestones, one of which was met on July 25, 2019, resulting in the vesting of the PSU as to 1,900 shares.

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1
  • filerCIK 0001612859

Filing Metadata

Form type
4
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 7:59 PM ET
Size
6.4 KB